UOC Surgical Oncology of the Digestive Tract
The unit of Surgical Oncology of the Esophagus and Digestive Tract carries out diagnosis, treatment and research on cancers of the digestive system, in particular on those of the esophagus, stomach, colon and rectum, the hepato-bilio-pancreatic area (pancreatic tumors, primary liver tumors and hepatic metastases) and on the primary and secondary tumors of the peritoneum (peritoneal carcinosis).
The management of the therapeutic-surgical path is multidisciplinary. Each patient is taken care of by a team of surgeons, oncologists, radiotherapists, endoscopists, pathologists and nutritionists at every stage of the pathway. The patient can also count on staff dedicated to organizing and booking exams and admissions. Thanks to this organizational model, the preparation for surgery mainly takes place on an outpatient basis, minimizing preoperative hospitalization, and after the procedure, pain therapy and nutritional aspects receive all the necessary attention.
Alongside ordinary hospitalizations, an oncology day surgery provides services to satisfy clinical needs connected to the positioning of vascular access systems for chemotherapy, as well as interventional radiology procedures.
The unit of Surgical Oncology of the Esophagus and Digestive Tract has all the most advanced technologies and is dedicated to the development of minimally invasive surgical techniques with which it performs most of the procedures.
Clinical and basic research is an integral part of diagnosis and treatment of these conditions, and offers patients the most innovative diagnostic and therapeutic pathways, even within experimental trials.
The main areas of research concern the pathology of gastroesophageal, colorectal, pancreatic cancers, and primary and secondary tumors of the peritoneum (peritoneal carcinosis), with particular interest in models of carcinogenesis, minimally invasive surgical approaches, use of disease biomarkers, quality of life in operated patients and development of advanced loco-regional treatments (hyperthermic intraperitoneal chemotherapy – HIPEC).